INR 38.19
(0.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Cash Flow | 9.37 Million | -6.76 Million | -7.89 Million | -6.9 Million | -9.97 Million |
Net Income | 15.43 Million | 5.36 Million | -3.08 Million | -325 Thousand | 2.27 Million |
Depreciation & Amortization | 83 Thousand | 67 Thousand | 9000.00 | - | - |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | -936 Thousand | -8.08 Million | -1.18 Million | -3.87 Million | -9.03 Million |
Other non-cash items | -2.02 Million | -536 Thousand | -1.17 Million | -1.23 Million | -3.21 Million |
Investing Cash Flow | -9.55 Million | 7.15 Million | 7.74 Million | 6.98 Million | 9.97 Million |
Investments in PPE | -155 Thousand | -123 Thousand | -61 Thousand | - | - |
Acquisitions | - | - | - | - | - |
Investment purchases | - | - | - | - | - |
Sales/Maturities of investments | - | - | 4.12 Million | 4.25 Million | 5.93 Million |
Other Investing Activities | -9.4 Million | 7.28 Million | 7.8 Million | 6.98 Million | 9.97 Million |
Financing Cash Flow | 16 Thousand | - | - | - | - |
Debt repayment | - | - | - | - | - |
Dividends payments | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - |
Other Financing Activities | 16 Thousand | - | - | - | - |
Accounts receivables | -506 Thousand | -140 Thousand | 7.65 Million | -2.72 Million | -8.86 Million |
Accounts payables | - | - | - | - | - |
Inventory | - | - | - | - | - |
Other working capital | -430 Thousand | -5.29 Million | -213 Thousand | -940 Thousand | -172 Thousand |
Cash at beginning of period | 530 Thousand | 140 Thousand | 288 Thousand | 208 Thousand | 208 Thousand |
Cash at end of period | 367 Thousand | 530 Thousand | 140 Thousand | 288 Thousand | 208 Thousand |
Capital Expenditure | -155 Thousand | -123 Thousand | -61 Thousand | - | - |
Effect of forex changes on cash | - | - | - | - | - |
Net cash flow / Change in cash | -163 Thousand | 390 Thousand | -148 Thousand | 80 Thousand | - |
Free Cash Flow | 9.22 Million | -6.89 Million | -7.95 Million | -6.9 Million | -9.97 Million |
Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 11.75 Million | 15.43 Million | -277 Thousand | 4.17 Million | -207 Thousand | 1.64 Million |
Depreciation & Amortization | - | 83 Thousand | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | -936 Thousand | - | - | - | - |
Other non-cash items | -11.75 Million | -2.02 Million | 277 Thousand | -4.17 Million | 207 Thousand | -1.64 Million |
Investing Cash Flow | - | -9.55 Million | - | - | - | - |
Investments in PPE | - | -155 Thousand | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | -9.4 Million | - | - | - | - |
Financing Cash Flow | - | 16 Thousand | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | 16 Thousand | - | - | - | - |
Accounts receivables | - | -506 Thousand | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | -430 Thousand | - | - | - | - |
Cash at beginning of period | - | 530 Thousand | - | - | - | - |
Cash at end of period | - | 367 Thousand | - | - | - | - |
Capital Expenditure | - | -155 Thousand | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | -163 Thousand | - | - | - | - |
Free Cash Flow | - | 9.22 Million | - | - | - | - |
LSI
ANDHRSUGAR
POROF
IGPL
3234
INSECTICID